
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
M.D. Anderson Cancer Center in Houston is testing RFID on two medications, Neupogen (filgrastim, Amgen) and Procrit (epoetin alfa, Ortho Biotech).






